Edition:
India

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

25.70HKD
12 Nov 2018
Change (% chg)

HK$0.30 (+1.18%)
Prev Close
HK$25.40
Open
HK$25.40
Day's High
HK$25.85
Day's Low
HK$25.15
Volume
218,060
Avg. Vol
805,852
52-wk High
HK$55.08
52-wk Low
HK$21.25

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical's Net Profit Down In Q3 And 9-Month
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS Q3 NET PROFIT DOWN 91.80 PERCENT Y/Y, 9-MONTH NET PROFIT DOWN 77.86 PERCENT Y/Y.  Full Article

Livzon Pharmaceutical Group Updates On Prelim FY Net Profit Attributable
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::FY PRELIM NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS OF LISTED CO ABOUT RMB1,127.51 MILLION – RMB1,250.5134 MILLION.  Full Article

Livzon Pharmaceutical Group Says Approved Appointment Of Huang Yuxuan As Vice President
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::APPROVED APPOINTMENT OF HUANG YUXUAN AS VICE PRESIDENT OF COMPANY.  Full Article

Livzon Pharmaceutical Group to sell 15 pct stake in pharmaceuticals firm for 66.2 mln yuan
Tuesday, 24 Apr 2018 

April 24(Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says it plans to sell 15 percent stake in a Guangdong-based pharmaceuticals company for 66.2 million yuan .Says it will hold 77.1 percent stake in the pharmaceuticals company after the transaction .  Full Article

Livzon Pharmaceutical's Q1 Net Profit Up 26.3 Pct Y/Y
Monday, 23 Apr 2018 

April 23 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS Q1 NET PROFIT UP 26.3 PERCENT Y/Y AT 347.4 MILLION YUAN ($55.08 million).  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says Zhuhai-based biotechnology unit received drug clinical trial approval for drug named Recombinant Human anti-RANKL Monoclonal Antibody Solution for Injection.  Full Article

Livzon Pharmaceutical Co Announces Change In Shareholding Structure Of Livzon MABPharm
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::CO & JOINCARE PHARMACEUTICAL INDUSTRY ENTERED FRAMEWORK AGREEMENT RELATING TO CAPITAL CONTRIBUTION TO LIVZON BIOLOGICS.‍ACQUISITION CONSIDERATION OF 100% OF EQUITY INTERESTS OF LIVZON MAB BY BIOLOGICS TO BE RMB600 MILLION​.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Livzon Pharmaceutical's net profits up in Q3, Jan-Sept
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK:Says Q3 net profit up 1,719.2 percent y/y at 3.7 billion yuan ($556.85 million), 9-month net profit up 590.7 percent y/y at 4.2 billion yuan.  Full Article

Livzon Pharmaceutical sees FY net profit attributable between RMB4.32 bln - RMB4.48 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::Sees FY net profit attributable between RMB4.32 billion - RMB4.48 billion.  Full Article